StonvexLoading…
StonvexStonvexStonvexCore line items from BWA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $3.53B | $14.32B | $10.74B | $7.15B |
Operating Income | $336.00M | $536.00M | $774.00M | $526.00M |
Net Income | $242.00M | $277.00M | $539.00M | $381.00M |
EPS (Diluted) | $1.16 | $1.28 | $2.48 | $1.75 |
Total Assets | $13.65B | $13.77B | $14.50B | $14.40B |
Total Liabilities | $8.01B | $8.15B | $8.35B | $8.33B |
Cash & Equivalents | Not available | $2.31B | Not available | Not available |
Free Cash Flow OCF − CapEx | $9.00M | $1.18B | $722.00M | $465.00M |
Shares Outstanding | 208.30M | 207.06M | 217.60M | 218.10M |